Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-083947)

Filing Details

Accession Number:: 0000950170-25-083947
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-09 18:50:36
Reporting Period:: 2025-06-06

Filing Date:: 2025-06-09
Accepted Time:: 2025-06-09 18:50:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1785279	Metagenomi Inc.	MGX	Biological Products, (No Disgnostic Substances) (2836)	813909017

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1996097	C. Brian Thomas	C/O Metagenomi, Inc. 5959 Horton Street, 7Th Floor Emeryville CA 94608	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-06-06	10,785	$1.75	2,517,491	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.